Abstract: The present invention relates to method of regulating mammalian target-of-rapamycin (mTOR) based on a novel finding of a regulating mechanism of mTOR by a phospholipase D (PLD), and Ras homolog enriched in brain (Rheb). Further, the present invention also relates to a method of screening inhibitors of mTOR, and a method and a composition for treating mTOR-related metabolic diseases by inhibitin mTOR.
Type:
Application
Filed:
August 3, 2007
Publication date:
December 10, 2009
Applicant:
Postech Academy Industry
Inventors:
Sung-Ho Ryu, Pann-Ghill Suh, Sang-Hoon Ha, Mi-Nam Lee, Hyun-Ju Lee, II-Shin Kim, Do-Hyung Kim, Tae-Hoon Lee